Development and validation of a multi-matrix LC–MS/MS method for quantification of 20 drugs in human postmortem and porcine surrogate matrices
Analytical and Bioanalytical Chemistry · 2026
DOI: 10.1007/s00216-026-06664-2 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Jeroen Roosendaal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Team Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlan…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Alternative matrices are increasingly used in postmortem toxicology when conventional specimens such as femoral blood are unavailable. However, quantitative multi-matrix methods covering a wide range of tissues remain limited. This study describes the development and fit-for-purpose validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification of 20 forensically relevant drugs in human and porcine postmortem matrices. Analytes and internal standards were extracted by methanol-based protein precipitation, followed by reversed-phase chromatography gradient separation and quantitation using a linear ion trap consisting of a quadrupole mass filter. A solvent calibration curve was used to analyze all matrices in a single analytical run. Validation was performed according to a modified fit-for-purpose approach focusing on accuracy, precision, selectivity, carry-over, matrix effect, dilution feasibility, and stability. Acceptance criteria were fulfilled for 89.3% of analyte-matrix combinations under standard criteria and 96.7% after predefined fit-for-purpose adjustments. Porcine matrices showed analytical performance comparable to human tissues, supporting their use as surrogate matrices for method development and validation. The developed LC-MS/MS method enables quantification of drugs across a broad range of alternative postmortem matrices using a single extraction and calibration approach. The method is intended for fast, reliable, and resource-efficient multi-matrix studies rather than absolute quantification in individual matrices and provides a practical tool for the investigation of postmortem redistribution processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Team Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlands. j.roosendaal@nfi.nl.
- Team Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlands.
- Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Zitieren
APA
Roosendaal, J., Verschoor, S., Touw, D. J., Kloos, D. P., & van der Hulst, R. (2026). Development and validation of a multi-matrix LC–MS/MS method for quantification of 20 drugs in human postmortem and porcine surrogate matrices. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-026-06664-2
Vancouver
Roosendaal J, Verschoor S, Touw DJ, Kloos DP, van der Hulst R. Development and validation of a multi-matrix LC–MS/MS method for quantification of 20 drugs in human postmortem and porcine surrogate matrices. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-026-06664-2
BibTeX
@article{Roosendaal2026,
author = {Roosendaal, Jeroen and Verschoor, Shirley and Touw, Daan J and Kloos, Dick-Paul and van der Hulst, Rogier},
title = {Development and validation of a multi-matrix LC–MS/MS method for quantification of 20 drugs in human postmortem and porcine surrogate matrices},
journal = {Analytical and Bioanalytical Chemistry},
year = {2026},
doi = {10.1007/s00216-026-06664-2}
}
EUVIMED